ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
RIC panel discusses pathway to fusion commercialization
Fusion leaders at the Nuclear Regulatory Commission’s annual Regulatory Information Conference discussed the path forward for regulating the burgeoning fusion industry. The speakers discussed government and private industry initiatives in the United States and United Kingdom, with a focus on efforts shaping the near-term deployment of commercial fusion machines.
A recurring theme was the need to explain the difference between fission and fusion. Representatives from the Department of Energy and Type One Energy highlighted this as an important distinction for regulators, as it will allow fusion to undergo its own independent maturation process for developing standards and regulations in the same way that fission has. Lea Perlas, Fusion Program director at the Virginia Department of Health, said that confusion between fission and fusion has been a common cause for misplaced concerns among community members surrounding Commonwealth Fusion Systems’ proposed fusion plant site near Richmond, Va.
R. G. Alsmiller, Jr., R. T. Santoro, J. Barish, And, J. M. Barnes
Fusion Science and Technology | Volume 4 | Number 3 | November 1983 | Pages 491-497
Technical Papers | Shielding | doi.org/10.13182/FST83-A22798
Articles are hosted by Taylor and Francis Online.
Calculated results of the dose rates from induced activity in the enclosure of the ELMO Bumpy Torus proof-of-principle device (EBT-P) are presented. A cylindrical model of EBT-P is used. EBT-P will have a hydrogen plasma and thus the plasma will not produce neutrons, but substantial numbers of photoneutrons will be produced and it is the induced activity from these photoneutrons that is considered. The activation dose rates are presented for a variety of operating times and times after shutdown. Dose rates ∼5 to 10 mrem/h at 1 h after shutdown are obtained and the major contributor to the dose rate at 1 h after shutdown is found to be 24Na (half-life = 15.0 h).
